Nucleic acid molecules and uses thereof
US11866704B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 6, 2020 |
| Grant date | Jan 9, 2024 |
| Priority date | — |
| Expiry date | Aug 12, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/32
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A method of treating a subject suffering from cancer comprising a step of administering an effective amount of a group of double-stranded RNA molecules to the subject, wherein the RNA molecule is isolated or derived from a bacteria of the genus Escherichia. A method of inhibiting growth or proliferation of cancer cells comprising a step of contacting said cells with said RNA molecule; and a pharmaceutical composition for treating cancer comprising said RNA molecule and a pharmaceutically tolerable excipient. Also a double-stranded RNA molecule and a recombinant vector comprising the double-stranded RNA molecule.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.